• Return to Headlines

Shares of Nektar Therapeut Fall Below Previous 52-Week Low

By Shiri Gupta

Shares of Nektar Therapeut (NASDAQ:NKTR) traded today at $16.64, breaking its 52-week low. This new low was reached on below average trading volume as 784,000 shares traded hands, while the average 30-day volume is approximately 2.8 million shares.

Nektar Therapeutics, a research-based biopharmaceutical company, discovers and develops drug candidates for cancer, auto-immune disease, and chronic pain in the United States.

In the past 52 weeks, Nektar Therapeut share prices have been bracketed by a current low of $16.64 and a high of $69.76 and are now at $16.64. In the last five trading sessions, the 50-day moving average (MA) has fallen 2.9% while the 200-day MA has slid 0.8%.

There is potential upside of 529.0% for shares of Nektar Therapeut based on a current price of $16.64 and an average consensus analyst price target of $104.67. Nektar Therapeut shares should first meet resistance at the 50-day moving average (MA) of $30.56 and find additional resistance at the 200-day MA of $35.15.

SmarTrend recommended that its subscribers protect gains by selling shares of Nektar Therapeut on July 17th, 2019 by issuing a Downtrend alert when the shares were trading at $32.33. Since that call, shares of Nektar Therapeut have fallen 47.1%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows nektar therapeut

Ticker(s): NKTR